The Park lab studies the molecular and cellular pathogenesis of hematopoietic disorders arising from hematopoietic stem/progenitor cells. We do so by directly comparing purified neoplastic hematopoietic stem/progenitor cells to their normal counterparts and interrogating their function in vivo and in vitro, using primary human cells whenever possible.
Christopher Y. Park, MD, PhD
Research FocusPhysician-scientist Christopher Park focuses on the identification and characterization of molecular pathways that regulate normal and malignant stem cells in the hematopoietic system.
- MD, PhD, College of Physicians and Surgeons, Columbia University
- Pang WW, Pluvinage JV, Price EA, Sridhar K, Arber DA, Greenberg PL, Schrier SL, Park CY, Weissman IL. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3011-6. doi: 10.1073/pnas.1222861110. Epub 2013 Feb 6
- McGowan KA, Pang WW, Bhardwaj R, Perez MG, Pluvinage JV, Glader BE, Malek R, Mendrysa SM, Weissman IL, Park CY, Barsh GS. Blood. Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood. 2011 Sep 29;118(13):3622-33. doi: 10.1182/blood-2010-11-318584. Epub 2011 Jul 25.
- Clinical Scientist, Doris Duke Foundation (2012)
- Scholar, American Federation of Aging Research (2011)
- New Investigator Award, DOD Bone Marrow Failure Research Program (2011)
- Fellow Scholar Award in Basic Research, American Society of Hematology (2009)
- K08 Mentored Clinical Scientist Research Career Development Award, National Institutes of Health/National Cancer Institute (2007)
- PhD with highest distinction, Columbia University College of Physicians and Surgeons (2001)
- Titus Munson Coan Prize for best essay in the biological sciences, Columbia University College of Physicians and Surgeons (2001)
- Young Investigator Award, Joint Meeting of the International Society for Interferon and Cytokine Research and the International Cytokine Society (1998)